Skip to main content

Table 1 Demographic characteristics of the study and control groups

From: The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial

 

Study Group N = 62

Control Group N = 59

p-value

Age, years (mean ± SD)

45.81 ± 10.83

43.83 ± 11.06

0.897

Post-menopause

18 (29.0%)

19 (32.2%)

0.839

Parity

1.91 ± 1.05

2.12 ± 1.23

0.327

IUD

8 (12.9%)

4 (6.7%)

0.268

Educational level (college or above)

22 (35.5%)

17 (28.8%)

0.652

Employed

42 (67.7%)

36 (61.0%)

0.559

History of TH

4 (6.5%)

7 (11.9%)

0.355

HR-HPV load (RLU/PC) (mean ± SD)

427.08 ± 771.50

416.06 ± 719.51

0.686

HR-HPV clearance

36 (58.1%)

32 (54.2%)

0.716

ASCUS/LSIL

13 (21.0%)

9 (15.3%)

0.522

  1. ASCUS/LSIL atypical squamous cell of undetermined significance/low-grade squamous intraepithelial lesion, HR-HPV high-risk human papilloma virus, IUD intra-uterine device, RLU/PC relative light unit/positive control, SD standard deviation, TH total hysterectomy